We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Standardizing methodologies to study microplastics and nanoplastics in cardiovascular diseases
AI summary Read the abstract
Researchers highlighted that microplastics and nanoplastics are emerging as new risk factors for cardiovascular health, with evidence indicating they can impair blood vessel cell functions and worsen artery-clogging processes. However, the widely varying concentrations of these particles found in heart and vascular tissues point to a lack of standardized research methods. The study calls for unified approaches to better understand how plastic particles affect the cardiovascular system.
Microplastics and nanoplastics (MNPs) are being recognized as new cardiovascular risk factors, impacting vascular cell functions and exacerbating atherosclerosis through diverse mechanisms. However, the varied concentrations of MNPs detected in major cardiovascular tissues highlight the urgent need for standardized research methodologies to better understand their impact and inform future health guidelines.
More Papers Like This
Microplastics and Nanoplastics in Cardiovascular Disease: An Emerging Cardiovascular Risk Factor
AI summary Read the abstract
Researchers reviewed mounting experimental and early clinical evidence that microplastics and nanoplastics cross epithelial barriers, accumulate in arterial plaques, cardiac tissue, and thrombi, and trigger oxidative stress and coagulation dysregulation, framing these particles as an emerging cardiovascular risk factor that warrants integration into disease prevention frameworks.
Analytical techniques for detecting micro- and nanoplastics in blood and vascular tissues: Strengths and limitations
AI summary Read the abstract
Researchers reviewed analytical techniques for detecting micro- and nanoplastics in blood and vascular tissues, assessing each method's strengths and limitations. The study highlights that human-derived samples pose unique challenges due to limited volumes, high lipid and protein content, and contamination risks, emphasizing the need for standardized protocols to produce reliable data for cardiovascular health research.
Micro- and nanoplastics as emerging cardiovascular risk factors: a new atherogenic player?
AI summary Read the abstract
This review summarizes existing research on tiny plastic particles called microplastics and nanoplastics, which are found in food, water, and human tissue. It reports that these particles may contribute to clogged, hardened arteries by causing cell stress, inflammation, and blood vessel problems, though current evidence does not prove they cause heart disease in people.
Microplastics and nanoplastics: Exposure and toxicological effects require important analysis considerations
AI summary Read the abstract
This review highlights that while microplastics and nanoplastics have been found in human tissues and linked to several diseases, the actual toxic effects are still unclear because researchers use very different methods to study them. The authors call for standardized testing approaches so that results can be compared reliably, which is critical for determining what levels of exposure actually pose a risk to human health.
The effects of microplastics and nanoplastics on cardiovascular disease: mechanisms and perspectives
AI summary Read the abstract
This review synthesizes current evidence on how microplastics and nanoplastics (MNPs) may contribute to cardiovascular disease, examining their presence in blood, atherosclerotic plaques, thrombi, and heart tissue. Experimental studies point to oxidative stress, mitochondrial dysfunction, inflammation, and fibrotic remodeling as plausible mechanisms linking MNP exposure to heart disease, though causal relationships in humans remain unproven and standardized detection methods are still lacking.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.